Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Neurocrine ( (NBIX) ) has shared an update.
Neurocrine Biosciences has appointed Dr. Kyle Gano as their new President and CEO starting October 11, 2024, with a generous compensation package including a $900,000 annual salary, potential 100% bonus, and varied equity grants totaling approximately $1.5 million, which vest over four years. Dr. Gano’s contract also outlines substantial severance benefits in the event of involuntary termination, with specifics dependent on the timing and context of his departure, including potential accelerated equity award vesting and health plan coverage.
Learn more about NBIX stock on TipRanks’ Stock Analysis page.
